Rodney Lappe

Rodney Lappe

Director/Board Member presso DESIGN THERAPEUTICS, INC.

Patrimonio netto: 536 087 $ in data 31/03/2024

69 anni
Health Technology
Consumer Services
Finance

Profilo

Rodney W.
Lappe
is currently the Director at Nucleus Biologics LLC and an Independent Director at Design Therapeutics, Inc. He previously worked as a Director at Mirati Therapeutics, Inc. and held the position of Senior Vice President at Tavistock Life Sciences Co. He also served as the VP-Cardiovascular & Metabolic Diseases at Pharmacia Corp.
and as the Group SVP-Worldwide Research & Development at Pfizer Inc. Additionally, he was the Chief Scientific Officer & Senior Vice President at CovX Research LLC.
Dr. Lappe completed his undergraduate degree at Blackburn College and obtained his doctorate from Indiana University.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
01/12/2023 133 024 ( 0.24% ) 536 087 $ 31/03/2024

Posizioni attive di Rodney Lappe

SocietàPosizioneInizio
DESIGN THERAPEUTICS, INC. Director/Board Member 01/07/2019
Director/Board Member -
Tutte le posizioni attive di Rodney Lappe

Precedenti posizioni note di Rodney Lappe

SocietàPosizioneFine
MIRATI THERAPEUTICS Chairman 15/02/2019
Chief Tech/Sci/R&D Officer 01/12/2011
PFIZER, INC. Chief Tech/Sci/R&D Officer 01/12/2011
Corporate Officer/Principal 01/12/2003
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Rodney Lappe

Formazione di Rodney Lappe

Blackburn College Undergraduate Degree
Indiana University Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Rodney Lappe

Relazioni

100 +

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa1
PFIZER, INC.

Health Technology

Aziende private6

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Design Therapeutics, Inc.

Vedi le connessioni aziendali